VNDA – vanda pharmaceuticals inc. (US:NASDAQ)
Stock Stats
News
Vanda Pharmaceuticals Announces Participation in the 2026 Citizens Life Sciences Conference
Vanda Pharmaceuticals Announces FDA Acceptance of Biologics License Application Filing for Imsidolimab for the Treatment of Generalized Pustular Psoriasis [Yahoo! Finance]
Vanda Pharmaceuticals Announces FDA Acceptance of Biologics License Application Filing for Imsidolimab for the Treatment of Generalized Pustular Psoriasis
Vanda Pharmaceuticals (NASDAQ:VNDA) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Vanda Pharmaceuticals stock surges after the FDA approves its new Bipolar I drug [Yahoo! Finance]
Form 4 Vanda Pharmaceuticals For: Feb 23 Filed by: Honore Tage
Form 144 Vanda Pharmaceuticals Filed by: Honore Tage
Form 8-K Vanda Pharmaceuticals For: Feb 20
Form 4 Vanda Pharmaceuticals For: Feb 18 Filed by: Wijkstrom Joakim
Form 4 Vanda Pharmaceuticals For: Feb 18 Filed by: Birznieks Gunther
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.